South Asians living in the UK and adherence to coronary heart disease medication: a mixed- method study

Zahraa Jalal1, Sotiris Antoniou2, David Taylor3

  • 1School of Pharmacy, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. z.jalal@bham.ac.uk.

Insights

South Asian patients often attribute coronary heart disease to factors beyond genetics and diet, such as fate. While their belief in medicine necessity is high, adherence to coronary heart disease medication decreases over time.

Area of Science:

  • Cardiology
  • Public Health
  • Health Psychology

Background:

  • Coronary heart disease (CHD) prevalence is disproportionately high in the UK's South Asian population.
  • Understanding patient beliefs is crucial for effective management and adherence.
  • This study focuses on South Asian patients' perspectives on CHD and medication.

Purpose of the Study:

  • To investigate South Asian patients' beliefs and experiences concerning coronary heart disease (CHD).
  • To explore medication-taking behaviors in South Asian patients with CHD.
  • To compare beliefs and adherence between South Asian and non-South Asian patients.

Main Methods:

  • Mixed-methods approach combining qualitative interviews and quantitative questionnaires.
  • Semi-structured telephone interviews with 14 South Asian patients.
  • Validated questionnaires (Morisky Scale, Belief About Medicines Questionnaire-Specific) administered to 71 patients (17 South Asian, 54 non-South Asian) over 6 months.

Main Results:

  • South Asian patients cited genetic factors, diet, and 'god's will' as causes of CHD.
  • Beliefs regarding the necessity of medication outweighed concerns among South Asian patients.
  • Medication adherence, measured by the Morisky Scale, decreased over time in both South Asian and non-South Asian groups.

Conclusions:

  • South Asian patients attribute CHD to diverse causes, including non-traditional risk factors.
  • Cultural context significantly influences prevention attitudes and disease experience.
  • Further research is needed to understand the impact of cultural factors on CHD management in this population.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
357
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
312
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
443
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
586
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267